Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Criterios y pautas de terapia combinada en la diabetes tipo 2. Documento de consenso de la Sociedad Española de Diabetes y de la Sociedad Española de Medicina Familiar y Comunitaria.
Endocrinología y Nutrición, 48 (2001), pp. 82-97
[2.]
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blodd pressure.
Arch Intern Med, 157 (1997), pp. 2413-2446
[3.]
A.R. Jadad, R.A. Moore, D. Carroll, C. Jenkinson, D.J. Reynolds, D.J. Gavaghan, et al.
Assessing the quality of reports of randomized clinical trials: is blinding necessary?.
Control Clin Trials, 17 (1996), pp. 1-12
[4.]
D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, D. Elbourne, et al.
The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
Ann Intern Med, 134 (2001), pp. 663-694
[5.]
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
Lancet, 352 (1998), pp. 854-865
[6.]
J. McCormark, T. Greenhalgh.
Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data.
Br Med J, 320 (2000), pp. 1720-1723
[7.]
R.A. DeFronzo, N. Barzilai, D.C. Simonson.
Mechanism of metformin action in obese and leand non insulin-dependent diabetic subjetcs.
J Clin Endocrinol Metab, 73 (1991), pp. 1294-1301
[8.]
R.A. De Fronzo.
Pharmacologic therapy for type 2 diabetes mellitus.
Ann Intern Med, 131 (1999), pp. 281-303
[9.]
J. Olsson, G. Lindberg, M. Gottsäter, K. Lindwall, A. Sjöstrand, A. Tisell, et al.
Increased mortality in type II diabetic patients using sulphonylurea and metformin in combination: a population-based observational study.
Diabetologia, 43 (2000), pp. 558-560
[10.]
P. Spallarossa, L. Olivotti, M. Schiavo, R. Cordera, P. Rossettin, C. Brunelli, et al.
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia.
Diabetes Care, 24 (2001), pp. 738-742
[11.]
R.R. Holman, C.A. Cull, R.C. Turner.
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44).
Diabetes Care, 22 (1999), pp. 960-964
Copyright © 2001. Sociedad Española de Endocrinología y Nutrición